Citing the Need for Pandemic Safety, Malaysia to Permit Remote Inspections of Some Pharmaceutical Plants
With the COVID-19 pandemic making it unsafe to conduct most on-site inspections, regulatory authorities in Malaysia are permitting remote assessments of some pharmaceutical manufacturing facilities outside the country. Malaysia’s Guidance Document on Foreign GMP Inspection, 7th edition, March 2021, published by Malaysia’s... Read More